March 29th 2023
Adding avelumab to VEGFR inhibitor axitinib may prolong survival and improve outcomes among patients with recurrent/metastatic adenoid cystic carcinoma.
Ernest Hawk Discusses the NCI-Designated Cancer Centers’ Joint Statement on the HPV VaccineJuly 15th 2016
In this interview we discuss a joint statement from MD Anderson and 68 other NCI-designated cancer centers that calls for increased HPV vaccination for the prevention of cancer.
Surveillance Sans Surgery Safe, Cost-Effective in Head and Neck CancerMarch 23rd 2016
Undergoing surveillance with PET/CT resulted in similar survival to planned neck dissection in patients with squamous cell carcinoma of the head and neck with nodal disease who have completed chemoradiotherapy.
Cetuximab Plus RT Linked With High Toxicity in Head and Neck CancerDecember 10th 2015
The combination of radiation therapy plus cetuximab had higher rates of acute toxicity among patients with locally advanced squamous cell carcinoma of the head and neck compared with radiation therapy plus cisplatin.
Salivary Gland Cancers: Biology and Systemic TherapyOctober 15th 2015
This article reviews the pathology and current evidence on systemic therapies for the management of advanced salivary gland cancers that are not amenable to local therapy.
Salivary Gland Cancers: The Challenges of Progress in Rare TumorsOctober 15th 2015
The diversity and complexity, combined with the rarity of salivary gland malignancies, lead to definite and distinct challenges in their study, and consequently in advancing treatment options for affected patients.
The New Face of Head and Neck Cancer: The HPV EpidemicSeptember 15th 2015
This review discusses current paradigms in the diagnosis and management of HPV-OPSCC, and we emphasize pertinent research questions to investigate going forward, including whether to deintensify treatment in these patients.
Implications of the New Face of Head and Neck CancerSeptember 15th 2015
Although screening methods for HPV-OPSCC have not yet been developed, population-based prevention may be achievable through HPV vaccination, but only if concerted efforts are made to increase vaccine uptake in the United States.
Increased Risk of Second Malignancies With Radioactive Iodine Therapy for Thyroid CancerApril 27th 2015
A new population-based study has found that patients with thyroid cancer who are treated with radioactive iodine therapy are at increased risk for developing salivary cancer as a second malignancy.